MRA issued a technical bulletin Thursday to publish information in accordance with the Emergency Rules for Manufacturing of Marihuana Products Intended for Inhalation filed on November 22, 2019.
Rule 3. Ingredients. (1) All inactive ingredients shall be clearly listed on the product label for any marihuana product intended for inhalation produced after the effective date of these rules. (2) A licensee is prohibited from adding an inactive ingredient to a marihuana product intended for inhalation unless it has been approved by the FDA for inhalation. The concentration of any inactive ingredient in a marihuana product intended for inhalation shall not exceed the maximum concentration listed in the FDA Inactive Ingredient database. (3) Processors and marihuana processors shall keep records of formulation for a minimum of two years after the use of the formulation is discontinued for all marihuana products intended for inhalation. (4) All records of formulation and changes to formulations must be submitted to the agency for all marihuana products intended for inhalation.
Any product created after November 22, 2019, must be accompanied by the Record of Formulation for Marijuana Products Intended for Inhalation. Please see the proceeding pages for additional information on how to compliantly submit documentation to the agency.
Acceptable Ingredients: Formulations for marijuana vape cartridges may include distillate and terpenes processed within the regulated market by licensed processors or distillate and terpenes (including botanically derived terpenes) brought in from the external market. The process and procedures for which those products move through the Record of Formulation process are outlined at this link: https://www.michigan.gov/documents/lara/Technical_Bulletin_-_Formulation_Record_Guidance_672585_7.pdf